Catalyst Wire Dossier Catalyst Wire Dossier

FOVIR

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for FOVIR, covering 2015-04-01 to 2015-04-01. Get the full timeline:

Most recent: Clinical Trial Update: Study Comparing Two Alternatives of Antiretroviral Therapy as Post-exposure Prophylaxis to HIV-1:FOVIR+EMTRICITABINA + LOPINAVIR/RITONAVIR VS TENOFOVIR+EMTRICITABINA + MARAVIROC (MARAVI-PEP) [Phase 4]

See pricing